Zusammenfassung
Schokolade, Alkohol und Kaffee sind Produkte, die aus dem täglichen Leben vieler Menschen nicht wegzudenken sind. Häufig werden diesen negative gesundheitliche Wirkungen nachgesagt, während neuere Untersuchungen in den letzten Jahren auch positive Effekte dieser Genussmittel im Hinblick auf kardiovaskuläre Erkrankungen nachweisen konnten. Als Ursache hierfür werden unter anderem Polyphenole verantwortlich gemacht, die z. B. in Kakao und Rotwein enthalten sind und antioxidative Wirkungen haben. Obwohl es unstrittig ist, dass übermäßiger Alkoholkonsum gesundheitsschädlich ist, gibt es auch Hinweise auf kardioprotektive Wirkungen. Kaffee, das beliebteste Getränk der Deutschen, enthält neben Polyphenolen noch zahlreiche weitere Inhaltsstoffe. Am besten untersucht ist das Koffein, das ebenso wie Alkohol in den letzten Jahren Gegenstand zahlreicher Untersuchungen war. Diese Übersichtsarbeit soll einen Überblick über die vorhandene Datenlage in Bezug auf die Wirkung von Schokolade, Alkohol und Kaffee auf kardiovaskuläre Erkrankungen geben.
Abstract
Chocolate, alcohol and coffee are widely consumed products and are often used on a daily basis. Formerly associated with negative health effects, more recent studies favor a beneficial effect of chocolate, alcohol and coffee with respect to cardiovascular diseases. This could be explained in part by the high content of polyphenols in cocoa and red wine that exert antioxidant properties. Although excessive alcohol consumption is unquestionably harmful, recent data suggested beneficial effects on cardiovascular diseases. Coffee, which is the most consumed beverage in Germany, contains polyphenols and also many other ingredients, such as caffeine. Caffeine as well as alcohol have been the subject of several trials in the past decade. This review summarizes the available data of the relationship between chocolate, alcohol and coffee consumption and cardiovascular diseases.
Literatur
http://de.statista.com/statistik/daten/studie/20040/umfrage/jaehrlicher-schokoladenkonsum-pro-kopf-in-ausgewaehlten-laender. Zugegriffen: 04. Nov. 2014
Deutsches Weininstitut. Deutscher Wein Statistik 2013/2014. http://www.deutscheweine.de. Zugegriffen: 04. Nov. 2014
http://de.statista.com/statistik/daten/studie/199898/umfrage/konsum-von-kaffee-in-europa. Zugegriffen: 04. Nov. 2014
http://www.who.int/mediacentre/factsheets/fs317/en. Zugegriffen: 04. Nov. 2014
Manach C, Scalbert A, Morand C et al (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79(5):727–747
Worm N, Belz GG, Stein-Hammer C (2013) Moderater Weingenuss und Prävention der koronaren Herzkrankheit. Dtsch Med Wochenschr 138(51–52):2653–2657
Bohn SK, Ward NC, Hodgson JM, Croft KD (2012) Effects of tea and coffee on cardiovascular disease risk. Food Funct 3(6):575–591
Tome-Carneiro J, Gonzalvez M, Larrosa M et al (2013) Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci 1290:37–51
Cano-Marquina A, Tarin JJ, Cano A (2013) The impact of coffee on health. Maturitas 75(1):7–21
Corti R, Flammer AJ, Hollenberg NK, Luscher TF (2009) Cocoa and cardiovascular health. Circulation 119(10):1433–1441
Cordova AC, Jackson LS, Berke-Schlessel DW, Sumpio BE (2005) The cardiovascular protective effect of red wine. J Am Coll Surg 200(3):428–439
Corder R (2008) Red wine, chocolate and vascular health: developing the evidence base. Heart 94(7):821–823
Pearson DA, Holt RR, Rein D et al (2005) Flavanols and platelet reactivity. Clin Dev Immunol 12(1):1–9
Flammer AJ, Sudano I, Wolfrum M et al (2012) Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur Heart J 33(17):2172–2180
Flammer AJ, Hermann F, Sudano I et al (2007) Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 116(21):2376–2382
Shiina Y, Funabashi N, Lee K et al (2009) Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol 131(3):424–429
Pereira T, Maldonado J, Laranjeiro M et al (2014) Central arterial hemodynamic effects of dark chocolate ingestion in young healthy people: a randomized and controlled trial. Cardiol Res Pract. doi:10.1155/2014/945951
Grassi D, Necozione S, Lippi C et al (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46(2):398–405
Loffredo L, Perri L, Catasca E et al (2014) Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease. J Am Heart Assoc 3(4):e001072
Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8(11):1227–1234
Innes AJ, Kennedy G, McLaren M et al (2003) Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets 14(5):325–327
Hamed MS, Gambert S, Bliden KP et al (2008) Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J 101(12):1203–1208
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219
Desch S, Schmidt J, Kobler D et al (2010) Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23(1):97–103
Buijsse B, Feskens EJ, Kok FJ, Kromhout D (2006) Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 166(4):411–417
Desch S, Kobler D, Schmidt J et al (2010) Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens 23(6):694–700
Taubert D, Berkels R, Roesen R, Klaus W (2003) Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 290(8):1029–1030
Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21(12):2281–2286
Engler MB, Engler MM, Chen CY et al (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23(3):197–204
Taubert D, Roesen R, Schomig E (2007) Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 167(7):626–634
Stamler R (1991) Implications of the INTERSALT study. Hypertension 17(1 Suppl):I16–I20
Janszky I, Mukamal KJ, Ljung R et al (2009) Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 266(3):248–257
Buitrago-Lopez A, Sanderson J, Johnson L et al (2011) Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 343:d4488. doi:10.1136/bmj.d4488
Petrone AB, Gaziano JM, Djousse L (2014) Chocolate consumption and risk of heart failure in the Physicians‘ Health Study. Eur J Heart Fail 16(12):1372–1376
Monagas M, Khan N, Andres-Lacueva C et al (2009) Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr 90(5):1144–1150
Arranz S, Valderas-Martinez P, Chiva-Blanch G et al (2013) Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans. Mol Nutr Food Res 57(6):936–947
Messerli FH (2012) Chocolate consumption, cognitive function, and Nobel laureates. N Engl J Med 367(16):1562–1564
Corder R, Mullen W, Khan NQ et al (2006) Oenology: red wine procyanidins and vascular health. Nature 444(7119):566
Hashimoto M, Kim S, Eto M et al (2001) Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 88(12):1457–1460, A9
Shimada K, Watanabe H, Hosoda K et al (1999) Effect of red wine on coronary flow-velocity reserve. Lancet 354(9183):1002
Hozumi T, Sugioka K, Shimada K et al (2006) Beneficial effect of short term intake of red wine polyphenols on coronary microcirculation in patients with coronary artery disease. Heart 92(5):681–682
Estruch R, Sacanella E, Badia E et al (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175(1):117–123
Chiva-Blanch G, Urpi-Sarda M, Llorach R et al (2012) Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am J Clin Nutr 95(2):326–334
Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R (2013) Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol 48(3):270–277
Droste DW, Iliescu C, Vaillant M et al (2013) A daily glass of red wine and lifestyle changes do not affect arterial blood pressure and heart rate in patients with carotid arteriosclerosis after 4 and 20 weeks. Cerebrovasc Dis Extra 3(1):121–129
Krenz M, Korthuis RJ (2012) Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol 52(1):93–104
St Leger AS, Cochrane AL, Moore F (1979) Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1(8124):1017–1020
Renaud S, Lorgeril M de (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339(8808):1523–1526
Gronbaek M, Deis A, Sorensen TI et al (1995) Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 310(6988):1165–1169
Lorgeril M de, Salen P, Martin JL et al (2002) Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 106(12):1465–1469
Corrao G, Rubbiati L, Bagnardi V et al (2000) Alcohol and coronary heart disease: a meta-analysis. Addiction 95(10):1505–1523
Ronksley PE, Brien SE, Turner BJ et al (2011) Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 342:d671. doi:10.1136/bmj.d671
Di CA, Costanzo S, Bagnardi V et al (2006) Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166(22):2437–2445
Hvidtfeldt UA, Tolstrup JS, Jakobsen MU et al (2010) Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation 121(14):1589–1597
Mukamal KJ, Chung H, Jenny NS et al (2005) Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke 36(9):1830–1834
Mukamal KJ, Chiuve SE, Rimm EB (2006) Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med 166(19):2145–2150
Zairis MN, Ambrose JA, Lyras AG et al (2004) C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study. Heart 90(4):419–424
Juonala M, Viikari JS, Kahonen M et al (2009) Alcohol consumption is directly associated with carotid intima-media thickness in Finnish young adults: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 204(2):e93–e98
World Health Organisation (2014) Global status report on alcohol and health. World Health Organisation Press, Geneva, Switzerland
Testino G, Patussi V, Scafato E et al (2013) Alcohol, cardiovascular disease and cancer. Alcohol Alcohol 48(5):627–628
Bergmann MM, Rehm J, Klipstein-Grobusch K et al (2013) The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol 42(6):1772–1790
O’Keefe JH, Bhatti SK, Bajwa A et al (2014) Alcohol and cardiovascular health: the dose makes the poison … or the remedy. Mayo Clin Proc 89(3):382–393
Gronroos NN, Alonso A (2010) Diet and risk of atrial fibrillation – epidemiologic and clinical evidence. Circ J 74(10):2029–2038
Matsumoto C, Miedema MD, Ofman P et al (2014) An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev 34(3):159–171
Jaubert MP, Jin Z, Russo C et al (2014) Alcohol consumption and ambulatory blood pressure: a community-based study in an elderly cohort. Am J Hypertens 27(5):688–694
Roerecke M, Rehm J (2014) Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart 1(1):e000135
Movva R, Figueredo VM (2014) Alcohol and the heart: to abstain or not to abstain? Int J Cardiol 172(3):628
Holmes MV, Dale CE, Zuccolo L et al (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 349:g4164. doi:10.1136/bmj.g4164
Smith GC, Pell JP (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 327(7429):1459–1461
Cornelis MC, El-Sohemy A (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18(1):13–19
Riksen NP, Rongen GA, Smits P (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther 121(2):185–191
Renda G, Zimarino M, Antonucci I et al (2012) Genetic determinants of blood pressure responses to caffeine drinking. Am J Clin Nutr 95(1):241–248
Klatsky AL, Hasan AS, Armstrong MA et al (2011) Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J 15(3):19–25
Frost L, Vestergaard P (2005) Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81(3):578–582
Conen D, Chiuve SE, Everett BM et al (2010) Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr 92(3):509–514
Graboys TB, Blatt CM, Lown B (1989) The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Intern Med 149(3):637–639
Pelchovitz DJ, Goldberger JJ (2011) Caffeine and cardiac arrhythmias: a review of the evidence. Am J Med 124(4):284–289
Caldeira D, Martins C, Alves LB et al (2013) Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart 99(19):1383–1389
Noordzij M, Uiterwaal CS, Arends LR et al (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23(5):921–928
Jee SH, He J, Whelton PK et al (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33(2):647–652
Giggey PP, Wendell CR, Zonderman AB, Waldstein SR (2011) Greater coffee intake in men is associated with steeper age-related increases in blood pressure. Am J Hypertens 24(3):310–315
Lane JD, Pieper CF, Phillips-Bute BG et al (2002) Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosom Med 64(4):595–603
Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB et al (2007) Coffee intake and incidence of hypertension. Am J Clin Nutr 85(3):718–723
Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC (2005) Habitual caffeine intake and the risk of hypertension in women. JAMA 294(18):2330–2335
Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E (2011) The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 94(4):1113–1126
Robertson D, Hollister AS, Kincaid D et al (1984) Caffeine and hypertension. Am J Med 77(1):54–60
Farag NH, Vincent AS, McKey BS et al (2005) Hemodynamic mechanisms underlying the incomplete tolerance to caffeine’s pressor effects. Am J Cardiol 95(11):1389–1392
Shechter M, Shalmon G, Scheinowitz M et al (2011) Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. Am J Cardiol 107(9):1255–1261
Buscemi S, Verga S, Batsis JA et al (2010) Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr 64(5):483–489
Freedman ND, Park Y, Abnet CC et al (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366(20):1891–1904
Koning Gans JM de, Uiterwaal CS, Schouw YT van der et al (2010) Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 30(8):1665–1671
Malerba S, Turati F, Galeone C et al (2013) A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 28(7):527–539
Greenberg JA, Chow G, Ziegelstein RC (2008) Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study). Am J Cardiol 102(11):1502–1508
Mukamal KJ, Hallqvist J, Hammar N et al (2009) Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 157(3):495–501
Larsson SC, Orsini N (2011) Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 174(9):993–1001
Wu JN, Ho SC, Zhou C et al (2009) Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 137(3):216–225
Reis JP, Loria CM, Steffen LM et al (2010) Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: the CARDIA study. Arterioscler Thromb Vasc Biol 30(10):2059–2066
Silletta MG, Marfisi R, Levantesi G et al (2007) Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico)-Prevenzione trial. Circulation 116(25):2944–2951
Ding M, Bhupathiraju SN, Satija A et al (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129(6):643–659
Mostofsky E, Rice MS, Levitan EB, Mittleman MA (2012) Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail 5(4):401–405
Palatini P (2012) Letter by Palatini regarding article, „Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis“. Circ Heart Fail 5(6):e98
Mostofsky E, Rice MS, Mittleman MA (2012) Response to letter regarding article, „habitual coffee consumption and risk of heart failure: a dose-response meta-analysis“. Circ Heart Fail 5:e99
Grosso G, Stepaniak U, Micek A et al (2014) Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr. doi:10.1007/s00394-014-0789-6
Einhaltung ethischer Richtlinien
Interessenkonflikt. T. Walter, J. Grüttner, M. Borggrefe und S. Swoboda geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walter, T., Grüttner, J., Borggrefe, M. et al. Schokolade, Alkohol und Kaffee. Kardiologe 9, 253–264 (2015). https://doi.org/10.1007/s12181-015-0660-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-015-0660-x